Glenn Matfin

11.3k total citations
40 papers, 692 citations indexed

About

Glenn Matfin is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Pharmacology. According to data from OpenAlex, Glenn Matfin has authored 40 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Molecular Biology and 9 papers in Pharmacology. Recurrent topics in Glenn Matfin's work include Diabetes Treatment and Management (12 papers), Pharmacology and Obesity Treatment (9 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). Glenn Matfin is often cited by papers focused on Diabetes Treatment and Management (12 papers), Pharmacology and Obesity Treatment (9 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). Glenn Matfin collaborates with scholars based in United States, United Kingdom and Japan. Glenn Matfin's co-authors include Richard Carroll, David R. Owens, Richard E. Pratley, L. Monnier, Richard Carroll, Richard Quinton, Howard S. Jacobs, Michael Besser, Veronique Duke and Gavin MacColl and has published in prestigious journals such as The Lancet, PLoS ONE and Fertility and Sterility.

In The Last Decade

Glenn Matfin

39 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Glenn Matfin United States 13 350 188 139 134 121 40 692
C. C. Chow Hong Kong 18 402 1.1× 270 1.4× 104 0.7× 125 0.9× 119 1.0× 34 893
Anna Noczyńska Poland 16 258 0.7× 141 0.8× 223 1.6× 61 0.5× 170 1.4× 84 818
Sinem Kıyıcı Türkiye 16 250 0.7× 159 0.8× 45 0.3× 139 1.0× 122 1.0× 38 732
Patty Y. Wang United States 8 344 1.0× 104 0.6× 54 0.4× 87 0.6× 54 0.4× 8 681
Ling Ge United States 11 483 1.4× 192 1.0× 73 0.5× 48 0.4× 110 0.9× 24 798
Areti Augoulea Greece 20 405 1.2× 135 0.7× 145 1.0× 520 3.9× 133 1.1× 86 1.5k
Sean Gow United Kingdom 15 516 1.5× 190 1.0× 68 0.5× 144 1.1× 56 0.5× 26 913
Penelope J. Hunt New Zealand 8 466 1.3× 129 0.7× 114 0.8× 35 0.3× 49 0.4× 9 872
Ekrem Algün Türkiye 15 293 0.8× 50 0.3× 58 0.4× 55 0.4× 119 1.0× 45 568
Nancy Greep United States 10 271 0.8× 84 0.4× 193 1.4× 61 0.5× 37 0.3× 15 595

Countries citing papers authored by Glenn Matfin

Since Specialization
Citations

This map shows the geographic impact of Glenn Matfin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn Matfin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn Matfin more than expected).

Fields of papers citing papers by Glenn Matfin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenn Matfin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn Matfin. The network helps show where Glenn Matfin may publish in the future.

Co-authorship network of co-authors of Glenn Matfin

This figure shows the co-authorship network connecting the top 25 collaborators of Glenn Matfin. A scholar is included among the top collaborators of Glenn Matfin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenn Matfin. Glenn Matfin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khamis, Amar Hassan, et al.. (2020). Clinical Characteristics and Outcomes of Patients With Diabetes Admitted for COVID-19 Treatment in Dubai: Single-Centre Cross-Sectional Study. JMIR Public Health and Surveillance. 6(4). e22471–e22471. 15 indexed citations
2.
Matfin, Glenn, et al.. (2015). Safe and Effective Use of the Once Weekly Dulaglutide Single-Dose Pen in Injection-Naïve Patients With Type 2 Diabetes. Journal of Diabetes Science and Technology. 9(5). 1071–1079. 43 indexed citations
3.
Zimmermann, Alan G., et al.. (2014). Patient Experience With The Single-Use Pen For Injection of Once Weekly Dulaglutide in Injection-Naive Patients With Type 2 Diabetes. Value in Health. 17(7). A354–A354. 1 indexed citations
4.
Matfin, Glenn, et al.. (2014). Safe and Effective Use of the Single-Use Pen for Injection of Once Weekly Dulaglutide in Injection-Naïve Patients with Type 2 Diabetes. Canadian Journal of Diabetes. 38(5). S27–S27. 1 indexed citations
5.
Xu, Yili, Jiayu Zhu, Li Gao, et al.. (2013). Hyperuricemia as an Independent Predictor of Vascular Complications and Mortality in Type 2 Diabetes Patients: A Meta-Analysis. PLoS ONE. 8(10). e78206–e78206. 76 indexed citations
6.
Matfin, Glenn. (2010). Review: Developing therapies for the metabolic syndrome: challenges, opportunities, and. . . the unknown. Therapeutic Advances in Endocrinology and Metabolism. 1(2). 89–94. 7 indexed citations
7.
Carroll, Richard & Glenn Matfin. (2010). Review: Endocrine and metabolic emergencies: thyroid storm. Therapeutic Advances in Endocrinology and Metabolism. 1(3). 139–145. 86 indexed citations
8.
Carroll, Richard & Glenn Matfin. (2010). Review: Endocrine and metabolic emergencies: hypercalcaemia. Therapeutic Advances in Endocrinology and Metabolism. 1(5). 225–234. 24 indexed citations
9.
Raskin, P., Glenn Matfin, Sherwyn Schwartz, et al.. (2007). Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts). Diabetes Obesity and Metabolism. 11(1). 27–32. 35 indexed citations
10.
Greenstein, Adam, Mitra Tavakoli, Moaz Mojaddidi, et al.. (2007). Review: Microvascular complications: evaluation and monitoring relevance to clinical practice, clinical trials, and drug development. The British Journal of Diabetes. 7(4). 166–171. 4 indexed citations
11.
Matfin, Glenn, Ali Jawa, & Vivian Fonseca. (2005). Erectile dysfunction: Interrelationship with the metabolic syndrome. Current Diabetes Reports. 5(1). 64–69. 26 indexed citations
12.
Matfin, Glenn. (2003). New treatments for erectile dysfunction. Fertility and Sterility. 80. 40–45. 5 indexed citations
13.
Matfin, Glenn, et al.. (2002). Klinefelter’s Syndrome Manifesting as an Acute Pulmonary Embolus in a 52-Year-Old Man. Endocrine Practice. 8(1). 68–69. 4 indexed citations
14.
Matfin, Glenn, et al.. (1999). Fever and dyspnoea in a young man with a rash. Postgraduate Medical Journal. 75(882). 251–253. 3 indexed citations
15.
Adelman, H M, et al.. (1998). A Confused Man with Rapid Respiration. Hospital Practice. 33(2). 19–23. 2 indexed citations
16.
Wallach, Paul M., et al.. (1998). An Inflamed Elbow After an Insect Sting. Hospital Practice. 33(6). 41–44. 1 indexed citations
17.
Brady, Patrick W., et al.. (1998). Complications Following Tube Gastrostomy. Hospital Practice. 33(4). 55–61. 1 indexed citations
18.
Wallach, Paul M., et al.. (1998). An Uncommon Cause of Oral Ulcers. Hospital Practice. 33(8). 11–14. 2 indexed citations
19.
Matfin, Glenn. (1995). Unilateral Adrenal Hyperplasia. Southern Medical Journal. 88(3). 376–376. 2 indexed citations
20.
Matfin, Glenn, R. Sheaves, Françoise Muscatelli, et al.. (1994). Gene deletion causing adrenal hypoplasia congenita and hypogonadotrophic hypogonadism. Clinical Endocrinology. 40(6). 807–808. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. C. Chow Breakdown of academic impact, for papers by Anna Noczyńska Breakdown of academic impact, for papers by Sinem Kıyıcı Breakdown of academic impact, for papers by Patty Y. Wang Breakdown of academic impact, for papers by Ling Ge Breakdown of academic impact, for papers by Areti Augoulea Breakdown of academic impact, for papers by Sean Gow Breakdown of academic impact, for papers by Penelope J. Hunt Breakdown of academic impact, for papers by Ekrem Algün Breakdown of academic impact, for papers by Nancy Greep
Rankless by CCL
2026